Table of Contents
Afrezza is an inhaled insulin used by people with diabetes to help control blood sugar levels. While it offers convenience and rapid action, it also requires careful monitoring to ensure safety. Regular lung function tests are crucial for users of Afrezza to prevent potential respiratory issues.
Why Lung Function Tests Are Important
Afrezza is administered through inhalation, which means it interacts directly with the lungs. While most users tolerate it well, some may experience lung-related side effects. Regular testing helps detect any changes or decline in lung function early, allowing for prompt medical intervention.
Potential Respiratory Risks
Although rare, some users may develop respiratory issues such as cough, wheezing, or shortness of breath. In some cases, the use of Afrezza has been associated with a decline in lung function, especially in individuals with pre-existing lung conditions like asthma or COPD.
Types of Lung Function Tests
- Spirometry: Measures how much air you can inhale and exhale, and how quickly.
- Peak Flow Measurement: Assesses the maximum speed of exhalation.
- Diffusion Capacity Tests: Evaluate how well gases transfer from lungs to blood.
Recommendations for Patients
Doctors typically recommend lung function tests before starting Afrezza and periodically during treatment. Patients should report any respiratory symptoms immediately. Maintaining regular testing ensures that any adverse effects are caught early, safeguarding lung health.
Conclusion
Using Afrezza requires a proactive approach to lung health. Regular lung function tests are essential to detect potential issues early and ensure safe, effective treatment. Always follow your healthcare provider’s guidance and report any respiratory concerns promptly.